These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30339710)

  • 1. Expression analysis of cyclooxygenase-2 in patients suffering from esophageal squamous cell carcinoma.
    Tasneem S; Sarwar MT; Bashir MR; Hussain H; Ahmed J; Pervez S
    PLoS One; 2018; 13(10):e0205508. PubMed ID: 30339710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of phospholipase A2 Group IIA in esophageal squamous cell carcinoma and association with cyclooxygenase-2 expression.
    Zhai YC; Dong B; Wei WQ; He Y; Li XQ; Cormier RT; Wang W; Liu F
    Asian Pac J Cancer Prev; 2014; 15(21):9417-21. PubMed ID: 25422234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexpression of COX-2 and iNOS in Angiogenesis of Superficial Esophageal Squamous Cell Carcinoma.
    Kumagai Y; Sobajima J; Higashi M; Ishiguro T; Fukuchi M; Ishibashi K; Mochiki E; Yakabi K; Kawano T; Tamaru J; Ishida H
    Int Surg; 2015 Apr; 100(4):733-43. PubMed ID: 25875558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.
    Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML
    Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and clinical significance of COX-2, p-Stat3, and p-Stat5 in esophageal carcinoma].
    Liu JR; Wang Y; Zuo LF; Li FL; Wang Y; Liu JL
    Ai Zheng; 2007 May; 26(5):458-62. PubMed ID: 17672932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
    Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B
    Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma.
    Pham QT; Oue N; Sekino Y; Yamamoto Y; Shigematsu Y; Sakamoto N; Sentani K; Uraoka N; Yasui W
    Oncology; 2018; 95(5):297-308. PubMed ID: 30134247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in Chinese patients with esophageal squamous cell carcinoma.
    Cui Y; Dong C; Wu BQ; Duan XC; Shi G; Gong M; Wang TY
    J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C44-8. PubMed ID: 26323923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2.
    Shao Y; Li P; Zhu ST; Yue JP; Ji XJ; Ma D; Wang L; Wang YJ; Zong Y; Wu YD; Zhang ST
    Oncotarget; 2016 Mar; 7(12):15173-86. PubMed ID: 26959737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of klotho and β-catenin in esophageal squamous cell carcinoma, and their clinicopathological and prognostic significance.
    Tang X; Fan Z; Wang Y; Ji G; Wang M; Lin J; Huang S
    Dis Esophagus; 2016 Apr; 29(3):207-14. PubMed ID: 25287007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of a low-frequency V1937I variant in FASN associated with susceptibility to esophageal squamous cell carcinoma.
    Wang X; Tian J; Zhao Q; Yang N; Ying P; Peng X; Zou D; Zhu Y; Zhong R; Gao Y; Chang J; Miao X
    Arch Toxicol; 2020 Jun; 94(6):2039-2046. PubMed ID: 32388819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of HLA-DQA1 predicts poor outcome in patients with esophageal squamous cell carcinoma in Northern China.
    Shen FF; Pan Y; Li JZ; Zhao F; Yang HJ; Li JK; Gao ZW; Su JF; Duan LJ; Lun SM; Zhang P; Tian LQ; Sun G; Huang D; Cao YT; Zhou FY
    Medicine (Baltimore); 2019 Feb; 98(8):e14454. PubMed ID: 30813145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-cancer Effects of a Novel Quinoline Derivative 83b1 on Human Esophageal Squamous Cell Carcinoma through Down-Regulation of COX-2 mRNA and PGE
    Pun IH; Chan D; Chan SH; Chung PY; Zhou YY; Law S; Lam AK; Chui CH; Chan AS; Lam KH; Tang JC
    Cancer Res Treat; 2017 Jan; 49(1):219-229. PubMed ID: 27456944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear PKM2 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma.
    Zhang X; He C; He C; Chen B; Liu Y; Kong M; Wang C; Lin L; Dong Y; Sheng H
    Pathol Res Pract; 2013 Aug; 209(8):510-5. PubMed ID: 23880164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic significance of cyclooxygenase-2 overexpression in esophageal squamous cell carcinoma.
    Kuo KT; Chow KC; Wu YC; Lin CS; Wang HW; Li WY; Wang LS
    Ann Thorac Surg; 2003 Sep; 76(3):909-14. PubMed ID: 12963227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of NS1-BP expression in esophageal squamous cell carcinoma].
    Ren K; Qian D; Wang YW; Pang QS; Zhang WC; Yuan ZY; Wang P
    Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):21-27. PubMed ID: 29365413
    [No Abstract]   [Full Text] [Related]  

  • 17. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
    Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
    Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COX-2 mRNA expression in esophageal squamous cell carcinoma (ESCC) and effect by NSAID.
    Liu X; Li P; Zhang ST; You H; Jia JD; Yu ZL
    Dis Esophagus; 2008; 21(1):9-14. PubMed ID: 18197933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 expression after preoperative chemoradiotherapy correlates with more frequent esophageal cancer recurrence.
    Yoshikawa R; Fujiwara Y; Koishi K; Kojima S; Matsumoto T; Yanagi H; Yamamura T; Hashimoto-Tamaoki T; Nishigami T; Tsujimura T
    World J Gastroenterol; 2007 Apr; 13(16):2283-8. PubMed ID: 17511025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of ERK1/2 MAPK signaling transduction pathway in esophageal cancers in Kazakh patients].
    Zheng ST; Liu T; Middottuersun A; Huo Q; Liu Q; Huang CG; Feng JG; Lü GD; Wang X; Lin RY; Sheyhidin I; Lu XM
    Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):421-5. PubMed ID: 21875481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.